![Hui Ou Yang](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Hui Ou Yang
Gründer bei MingMed Biotechnology Co., Ltd.
Aktive Positionen von Hui Ou Yang
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
MingMed Biotechnology Co., Ltd.
![]() MingMed Biotechnology Co., Ltd. BiotechnologyHealth Technology MingMed Biotechnology Co., Ltd. engages in the self-discovery and development of innovative drugs. Its core product QA102 is a small molecule drug candidate for the treatment of dry age-related macular degeneration. The company was founded by Guo Ming Huang, Yan Zhang, Xue Bin Liao, Hui Ou Yang, Lai Wei, Miao Liu and Ming Jin on November 26, 2019 and is headquartered in Guangzhou, China. | Gründer | 25.11.2019 | - |
Technik-/Wissenschafts-/F&E-Leiter | 19.12.2019 | - | |
Direktor/Vorstandsmitglied | 25.11.2019 | 27.07.2022 |
Karriereverlauf von Hui Ou Yang
Ausbildung von Hui Ou Yang
Peking University Health Science Center | Graduate Degree |
University of North Carolina at Chapel Hill | Doctorate Degree |
University of California, Los Angeles | Masters Business Admin |
Statistik
International
China | 3 |
2 | |
Vereinigte Staaten | 2 |
Operativ
Director/Board Member | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Founder | 1 |
Sektoral
Consumer Services | 4 |
Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
MingMed Biotechnology Co., Ltd.
![]() MingMed Biotechnology Co., Ltd. BiotechnologyHealth Technology MingMed Biotechnology Co., Ltd. engages in the self-discovery and development of innovative drugs. Its core product QA102 is a small molecule drug candidate for the treatment of dry age-related macular degeneration. The company was founded by Guo Ming Huang, Yan Zhang, Xue Bin Liao, Hui Ou Yang, Lai Wei, Miao Liu and Ming Jin on November 26, 2019 and is headquartered in Guangzhou, China. | Health Technology |
- Börse
- Insiders
- Hui Ou Yang
- Erfahrung